Return to content in this issue
Safety and Effectiveness of Dupilumab in Prurigo Nodularis
Romano C
Clinical Immunology Outpatient Clinic – Division of Internal Medicine, Department of Advanced Medical and Surgical Sciences, “Luigi Vanvitelli” University of Campania, Naples, Italy
J Investig Allergol Clin Immunol 2021; Vol 31(2)
: 162-163
doi: 10.18176/jiaci.0550
Key words: Dupilumab, Prurigo nodularis, Safety, Congestive heart failure
| Title | Type | Size | |
|---|---|---|---|
 |
doi10.1876_jiaci.0550_material-suppl_1.pdf | 577.63 Kb |
